FIELD: medicine.
SUBSTANCE: what is found is a pre-therapeutic rate of haemopoietic stem cells with immunophenotype CD34+CD45 low among peripheral lymphocytes at the stages T3 or T4 to be compared to its discrimination level of 6.0×10-4. If the value occurs to exceed 6.0×10-4, a high radiosensitivity of the tumour is predicted, while the value of 6.0×10-4 or less enables predicting a low radiosensitivity of the tumour.
EFFECT: using the presented method enables predicting the radiosensitivity of the malignant growths to irradiation for the purpose of indicating for the radiation therapy in the patients with the stage T3 or T4 of airway cancer.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RADIOSENSITIVITY OF MALIGNANT GROWTHS OF UPPER RESPIRATORY TRACT | 2020 |
|
RU2735982C2 |
| METHOD FOR ASSESSING PERSONIFIED RADIOSENSITIVITY OF PERSON BASED ON DETERMINING RESPONSE OF HIS HAEMOPOIETIC STEM CELLS TO RADIATION EXPOSURE USING HUMANIZED MICE | 2022 |
|
RU2817984C1 |
| BIOMEDICAL CELL PRODUCT, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2741769C2 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
| METHOD OF FORECASTING TUMOUR SUSCEPTIBILITY TO RADIATION THERAPY FOR RECTAL CANCER PATIENTS | 2007 |
|
RU2349916C1 |
| METHOD OF EARLY MOLECULAR-BIOLOGICAL DIAGNOSIS OF MALIGNANT GROWTHS AND AMYOTROPHIC LATERAL SCLEROSIS | 2018 |
|
RU2706714C1 |
| BIOMEDICAL CELL PREPARATION | 2017 |
|
RU2647429C1 |
| METHOD FOR PREDICTION OF EARLY RECURRENCE IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA | 2019 |
|
RU2702360C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
| METHOD FOR EVALUATING EFFICACY OF RADIOPROTECTIVE DRUGS USING HUMANISED MICE | 2023 |
|
RU2817986C1 |
